menu
    • menu
    [{"orgOrder":0,"company":"Aker BioMarine","sponsor":"Aker BioMarine","pharmaFlowCategory":"D","therapeuticArea":"Neurology","country":"CANADA","productType":"Small molecule","year":"2021","type":"Collaboration","leadProduct":"Icosapent Ethyl","moa":"","graph1":"Neurology","graph2":"Preclinical","graph3":"Aker BioMarine","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"","sponsorNew":"Aker BioMarine \/ Aker BioMarine","highestDevelopmentStatusID":"4","companyTruncated":"Aker BioMarine \/ Aker BioMarine"}]

    Find Clinical Drug Pipeline Developments & Deals by Aker BioMarine

    Menu

    Aker BioMarine

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Aker BioMarine

                            Norway arrow
                            Pharmtech & Ingredients
                            Not Confirmed

                            Aker BioMarine

                            Norway arrow
                            Pharmtech & Ingredients
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Icosapent Ethyl,DHA

                            Therapeutic Area : Neurology

                            Study Phase : Preclinical

                            Recipient : Université de Sherbrooke Department of Medicine

                            Deal Size : Undisclosed

                            Deal Type : Collaboration

                            DEALS_DEV arrow-down

                            Aker BioMarine Enters Into Research Collaboration for Alzheimer’s

                            Details : Université de Sherbrooke in Canada will test if LYSOVETA, Aker BioMarine’s new delivery platform based on LPC-bound EPA/DHA from krill, is more effective in increasing the concentration of DHA in the brain and improving cognition.

                            Brand Name : Lysoveta

                            Molecule Type : Small molecule

                            Upfront Cash : Undisclosed

                            February 15, 2021

                            Lead Product(s) : Icosapent Ethyl,DHA

                            Therapeutic Area : Neurology

                            Highest Development Status : Preclinical

                            Recipient : Université de Sherbrooke Department of Medicine

                            Deal Size : Undisclosed

                            Deal Type : Collaboration

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth